Solid Bio wins new Buy at Guggenheim on lead asset

2026-03-20 10:24:02 ET More on Solid Biosciences Solid Biosciences Inc. (SLDB) Presents at Barclays 28th Annual Global Healthcare Conference Transcript Solid Biosciences: Interim Data Lends Credibility For Q1 2026 Trial Start Solid Biosciences Inc. (SLDB) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript Solid Bio falls amid new trial data for Duchenne drug Biotech firm stocks rise on FDA vaccine head's exit Read the full article on Seeking Alpha For further details see: Solid Bio wins new Buy at Guggenheim on lead asset